Patrick Markt Vice President, Digital Excellence Daiichi-Sankyo
Andrew Gapper Director, Global Commercial Learning, Specialty Care Sanofi
Lucy George Head of Business Innovation, Oncology UK AstraZeneca
Paul Simms Chief Executive Impatient Health
There are no longer any excuses. The pandemic is no longer a key factor. Our performance, good or bad, is within our grasp, and our launch strategy has to be perfect.
Yet we are currently far from perfect. Recently, IQVIA published its latest whitepaper on post-pandemic launch excellence, describing how just 6% of specialty and 4% of primary care launches could be described as ‘excellent’.
This webinar is designed to illustrate how companies are getting ahead of the curve, installing the power and responsibility with key departments in order to give new techniques a greater chance of success. We want to demonstrate how leading players are adopting new approaches, from modular content delivery to self-detailing. And, of course, we’ll address new ways to ensure relevance and resonance in this ever-changing environment.